Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab.

Guillaume HerbreteauAlexandra LanglaisLaurent GreillierClarisse Audigier-ValetteLionel UwerJosé HureauxDenis Moro-SibilotFlorian GuisierDelphine CarmierJeannick MadelaineJosiane OttoPierre-Jean SouquetValérie GounantPatrick MerleOlivier MolinierAldo RenaultAudrey RabeauFranck MorinMarc Guillaume DenisJean-Louis Pujol

Published in: Journal of clinical medicine (2020)

ctDNA is strongly associated with the prognosis of SCLC patients treated with second-line immunotherapy. Its analysis seems justified for future SCLC clinical trials.

Keyphrases

circulating tumor
small cell lung cancer
cell free
circulating tumor cells
clinical trial
current status
brain metastases
study protocol